We have previously demonstrated that MUC1-EGFR complexes are capable of localizing around and entering the nucleus, acting as a co-transcriptional activator of genes upregulated in breast cancer, such as cyclin D1 [20]. The gene discussed is EGFR; the disease is breast carcinoma.